术中创口内局部应用抗生素对大鼠脊柱融合的影响:万古霉素与妥布霉素比较
研究在大鼠后外侧腰椎融合模型中比较术中局部应用万古霉素与妥布霉素对融合的影响。结果显示高剂量万古霉素可能对融合块形成有不利影响,未观察到妥布霉素对融合块形成的抑制作用。
要点
- 高剂量万古霉素组融合块体积18.8±7.9 mm³,低于对照组29.3±6.2 mm³(p<0.05)。
- 高剂量妥布霉素组融合块体积43.8±11.9 mm³,高于对照组29.3±6.2 mm³(p<0.05)。
- 高剂量万古霉素组手法触诊评分0.68±0.62,低于对照组1.46±0.58(p<0.05)。
核心结论
- 术中局部应用万古霉素,尤其是超生理剂量,可能对融合块形成有不利影响。
- 未观察到妥布霉素对融合块形成的抑制作用。
研究设计与样本
- 在60只雌性Lewis大鼠(6至8周龄)上行单节段(L4-L5)双侧后外侧横突间腰椎融合术,使用同基因髂嵴同种异体骨混合临床骨移植替代物及不同浓度抗生素,每组12只。
- 分组为:无抗生素对照组、低剂量万古霉素(14.3 mg/kg)、高剂量万古霉素(71.5 mg/kg)、低剂量妥布霉素(28.6 mg/kg)、高剂量妥布霉素(143 mg/kg)。
- 术后8周通过微计算机断层扫描(µCT)、手法触诊和组织学分析评估融合,评估对治疗组设盲。
- µCT分析测量每只大鼠的融合块体积;手法触诊评分量表为2至0分(2=融合,1=部分融合,0=未融合)。
主要发现
- µCT融合块体积均值:对照组29.3±6.2 mm³,低剂量万古霉素组26.3±8.9 mm³,高剂量万古霉素组18.8±7.9 mm³,低剂量妥布霉素组32.7±9.0 mm³,高剂量妥布霉素组43.8±11.9 mm³(对照组 vs 高剂量万古霉素组 p<0.05;对照组 vs 高剂量妥布霉素组 p<0.05)。
- 手法触诊评分均值:对照组1.46±0.58,低剂量万古霉素组0.86±0.87,高剂量万古霉素组0.68±0.62,低剂量妥布霉素组1.25±0.71,高剂量妥布霉素组1.32±0.72(对照组 vs 高剂量万古霉素组 p<0.05)。
- 组织学分析显示脊柱融合体积有相似趋势。
临床怎么用
- 脊柱外科医生在脊柱融合术中决定使用术中创口内抗生素时,应权衡手术部位感染减少与对融合可能的抑制作用。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Local, intrawound use of antibiotic powder, such as vancomycin and tobramycin, in spinal fusion surgery has become an increasingly common prophylactic measure in an attempt to reduce rates of postsurgical infection. However, the effects of localized antibiotic delivery on fusion remain unclear. The objective of this study was to examine the in vivo effects of intraoperative local delivery of 2 antibiotics commonly used in bone-grafting surgery on spinal fusion outcomes in a rat model. METHODS: Single-level (L4-L5), bilateral posterolateral intertransverse process lumbar fusion surgery was performed on 60 female Lewis rats (6 to 8 weeks of age) using syngeneic iliac crest allograft mixed with clinical bone-graft substitute and varying concentrations of antibiotics (n = 12 each): (1) control without any antibiotics, (2) low-dose vancomycin (14.3 mg/kg), (3) high-dose vancomycin (71.5 mg/kg), (4) low-dose tobramycin (28.6 mg/kg), and (5) high-dose tobramycin (143 mg/kg). Eight weeks postoperatively, fusion was evaluated via micro-computed tomography (µCT), manual palpation, and histological analysis, with blinding to treatment group. In the µCT analysis, fusion-mass volumes were measured for each rat. Each spine specimen (L4-L5) was rated (manual palpation score) on a scale of 2 to 0 (2 = fused, 1 = partially fused, and 0 = non-fused). RESULTS: The mean fusion-mass volume on µCT (mm) was as follows: control, 29.3 ± 6.2; low-dose vancomycin, 26.3 ± 8.9; high-dose vancomycin, 18.8 ± 7.9; low-dose tobramycin, 32.7 ± 9.0; and high-dose tobramycin, 43.8 ± 11.9 (control versus high-dose vancomycin, p < 0.05; and control versus high-dose tobramycin, p < 0.05). The mean manual palpation score for each group was as follows: control, 1.46 ± 0.58; low-dose vancomycin, 0.86 ± 0.87; high-dose vancomycin, 0.68 ± 0.62; low-dose tobramycin, 1.25 ± 0.71; and high-dose tobramycin, 1.32 ± 0.72 (control versus high-dose vancomycin, p < 0.05). The histological analyses demonstrated a similar trend with regard to spinal fusion volume. CONCLUSIONS: Intraoperative local application of vancomycin, particularly at a supraphysiological dosage, may have detrimental effects on fusion-mass formation. No inhibitory effect of tobramycin on fusion-mass formation was observed. CLINICAL RELEVANCE: When spine surgeons decide to use intraoperative intrawound antibiotics in spinal fusion surgery, they should weigh the reduction in surgical site infection against a possible inhibitory effect on fusion.
引用
- Ishida W, Perdomo-Pantoja A, Elder BD, et al. Effects of Intraoperative Intrawound Antibiotic Administration on Spinal Fusion: A Comparison of Vancomycin and Tobramycin in a Rat Model. J Bone Joint Surg Am. 2019. PMID: 31577679. doi:10.2106/JBJS.18.00988
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。